Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

RenovoRx Publishes Positive Early-Stage Data On TAMP Therapy For Locally Advanced Pancreatic Cancer

Author: Benzinga Newsdesk | July 31, 2024 08:41am

Chemotherapy Delivered Via TAMP With Prior Chemoradiation Shows 27-Month Overall Survival; Ongoing Phase III Trial Evaluates Targeted Chemotherapy Delivery; Study Published In The Oncologist

Posted In: RNXT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist